And I had just the opposite experience two weeks ago. On two different days I was trying to add to my position, but my orders to buy went unfilled. You're right though, the trading activity of VSCP has become a little different of late. Volume certainly has decreased. I'm still of the opinion (and hope!) that this stock will take off.
Yes, during the last quarterly earnings conference, they also discussed a plan to seek out a partner.
I guess what concerns me is that often when a company like VSCP hits the stage where a partner is being sought out, the rate of growth often slows down and consequently the stock price stagnates or falls. Any thoughts??
i was referring to commentary they made on the last call. and couple that with the presentation they gave last week at the Rodman and Renshaw conference (CFO essentially said they are in discussions with possible partners). I expect good things on the upcoming call.
from the earnings call, i gather second half of 2010 to be safe, and around the next earnings call more realistically. i'm hopeful that people who have been patient will be very well rewarded. of course, this applies to the rest of the CRO industry as well- pretty much every company has been beat up. every microcap has done poorly too. vscp has the most upside during any recovery.
personally i don't think vscp will make the transition to the molecular world without heavily investing a new business vertical. that seems unlikely to me, and a big distraction to the core business.
the action today and volume spike arent entirely surprising given that today is triple witching (the massive contract expiration day). i bet some algorithm and bank trading led to shorting of vscp to hedge their index exposure (especially nwo that vscp is in the russell microcap).
the last time this happened was june 18 and the stock was down about 5% as well.